Chinese guidelines for diagnosis and treatment of influenza (2011).
作者信息
Zhong Nan-Shan, Li Yi-Min, Yang Zi-Feng, Wang Chen, Liu You-Ning, Li Xing-Wang, Shu Yue-Long, Wang Guang-Fa, Gao Zhan-Cheng, Deng Guo-Hua, He Li-Xian, Xi Xiu-Ming, Cao Bin, Shen Kun-Ling, Wu Hao, Zhou Ping-An, Li Qing-Quan
机构信息
National Key Laboratory of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical College/Institute of Respiratory Diseases;
出版信息
J Thorac Dis. 2011 Dec;3(4):274-89. doi: 10.3978/j.issn.2072-1439.2011.10.01.
Abstract
摘要
相似文献
1
Chinese guidelines for diagnosis and treatment of influenza (2011).《中国流感诊断与治疗指南（2011年版）》
J Thorac Dis. 2011 Dec;3(4):274-89. doi: 10.3978/j.issn.2072-1439.2011.10.01.
2
Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines.成人流感中医临床实践指南
Pharmacol Res. 2020 Oct;160:105101. doi: 10.1016/j.phrs.2020.105101. Epub 2020 Jul 31.
3
2014 update of the Chinese guidelines for diagnosis and treatment of avian influenza A(H7N9) virus infection.《人感染H7N9禽流感诊疗方案（2014年版）》
Chin Med J (Engl). 2014;127(13):2543-7.
4
Clinical outcomes of influenza-like illness treated with Chinese herbal medicine: an observational study.中药治疗流感样疾病的临床疗效：一项观察性研究。
J Tradit Chin Med. 2018 Feb;38(1):107-116.
5
[Technical guidelines for seasonal influenza vaccination in China (2019-2020)].《中国季节性流感疫苗接种技术指南（2019—2020年）》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jan 6;54(1):21-36. doi: 10.3760/cma.j.issn.0253-9624.2020.01.007.
6
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南（2020—2021年）》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.
7
[Multi-dimensional mining and analysis of core prescriptions in launched Chinese patent medicine for treatment of influenza].[上市中成药治疗流感核心处方的多维挖掘与分析]
Zhongguo Zhong Yao Za Zhi. 2019 Nov;44(21):4738-4744. doi: 10.19540/j.cnki.cjcmm.20190812.501.
8
China is closely monitoring an increase in infection with avian influenza A (H7N9) virus.中国正在密切监测甲型H7N9禽流感病毒感染病例的增加情况。
Biosci Trends. 2017 Mar 22;11(1):122-124. doi: 10.5582/bst.2017.01041. Epub 2017 Feb 28.
9
[Review of prevention and treatment on influenza A (H1N1) with traditional Chinese medicine].[甲型H1N1流感的中医药防治综述]
Zhongguo Zhong Yao Za Zhi. 2010 Jul;35(14):1900-3. doi: 10.4268/cjcmm20101430.
10
Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials.中药治疗甲型 H1N1 流感：随机对照试验的系统评价。
PLoS One. 2011;6(12):e28093. doi: 10.1371/journal.pone.0028093. Epub 2011 Dec 2.
引用本文的文献
1
A 14-year influenza reinfection surveillance in Chongqing, China: A retrospective analysis.中国重庆14年流感再感染监测：一项回顾性分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2497576. doi: 10.1080/21645515.2025.2497576. Epub 2025 May 5.
2
Population-Based Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection in Southern China, 2023-2024 Season.2023 - 2024年中国南方地区基于人群的流感疫苗对实验室确诊流感感染的有效性
Open Forum Infect Dis. 2024 Aug 21;11(9):ofae456. doi: 10.1093/ofid/ofae456. eCollection 2024 Sep.
3
Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study.流感和 COVID-19 合并感染以及疫苗对重症病例的有效性：一项数学建模研究。
Front Cell Infect Microbiol. 2024 Mar 4;14:1347710. doi: 10.3389/fcimb.2024.1347710. eCollection 2024.
4
Risk factors for hospitalization and pneumonia development of pediatric patients with seasonal influenza during February-April 2023.2023 年 2 月至 4 月期间季节性流感住院和肺炎发生的儿科患者的风险因素。
Front Public Health. 2024 Jan 5;11:1300228. doi: 10.3389/fpubh.2023.1300228. eCollection 2023.
5
Associations between Short-Term Exposure to Ambient Air Pollution and Influenza: An Individual-Level Case-Crossover Study in Guangzhou, China.短期暴露于大气污染与流感的关联：来自中国广州的个体水平病例交叉研究。
Environ Health Perspect. 2023 Dec;131(12):127009. doi: 10.1289/EHP12145. Epub 2023 Dec 11.
6
Real-world experience of arbidol for Omicron variant of SARS-CoV-2.阿比朵尔治疗新型冠状病毒奥密克戎变异株的真实世界经验。
J Thorac Dis. 2023 Feb 28;15(2):452-461. doi: 10.21037/jtd-22-980. Epub 2023 Feb 5.
7
Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines.应对大流行的准备：大流行性流感临床管理指南的系统评价。
BMC Med. 2022 Nov 7;20(1):425. doi: 10.1186/s12916-022-02616-6.
8
Role of plasmonics in detection of deadliest viruses: a review.表面等离子体激元学在最致命病毒检测中的作用：综述
Eur Phys J Plus. 2021;136(6):675. doi: 10.1140/epjp/s13360-021-01657-9. Epub 2021 Jun 20.
9
Joint Predictors of Hypertension and Type 2 Diabetes Among Adults Under Treatment in Amhara Region (North-Western Ethiopia).阿姆哈拉地区（埃塞俄比亚西北部）接受治疗的成年人中高血压和2型糖尿病的联合预测因素
Diabetes Metab Syndr Obes. 2021 Jun 1;14:2453-2463. doi: 10.2147/DMSO.S309925. eCollection 2021.
10
Similarity and Specificity of Traditional Chinese Medicine Formulas for Management of Coronavirus Disease 2019 and Rheumatoid Arthritis.用于治疗新型冠状病毒肺炎和类风湿关节炎的中药方剂的相似性与特异性
ACS Omega. 2020 Nov 18;5(47):30519-30530. doi: 10.1021/acsomega.0c04377. eCollection 2020 Dec 1.
本文引用的文献
1
Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic.流感肺炎：季节性流感病毒和 H1N1 大流行的比较。
Eur Respir J. 2011 Jul;38(1):106-11. doi: 10.1183/09031936.00125910. Epub 2010 Nov 25.
2
Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection.入住 ICU 时对重症大流行（H1N1）v 型甲型流感感染患者使用早期皮质类固醇治疗。
Intensive Care Med. 2011 Feb;37(2):272-83. doi: 10.1007/s00134-010-2078-z. Epub 2010 Nov 24.
3
Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.季节性流感相关死亡人数的估计——美国，1976-2007 年。
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62.
4
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.中国社区获得性肺炎门诊成年患者病毒和肺炎支原体合并感染及新型临床结局评估。
Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1443-8. doi: 10.1007/s10096-010-1003-2. Epub 2010 Jul 11.
5
Differing symptom patterns in early pandemic vs seasonal influenza infections.大流行早期与季节性流感感染的不同症状模式。
Arch Intern Med. 2010 May 24;170(10):861-7. doi: 10.1001/archinternmed.2010.108.
6
A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic.一项系统综述，旨在为机构在 H1N1 流感大流行期间使用体外膜肺氧合的决策提供信息。
Crit Care Med. 2010 Jun;38(6):1398-404. doi: 10.1097/CCM.0b013e3181de45db.
7
When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia.何时考虑使用抗生素治疗2009年甲型H1N1流感相关性肺炎。
N Engl J Med. 2009 Dec 10;361(24):e112. doi: 10.1056/NEJMopv0910749.
8
Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection.因新型 2009 流感 A(H1N1)感染而入住犹他州 ICU 的临床发现和人口统计学因素。
Chest. 2010 Apr;137(4):752-8. doi: 10.1378/chest.09-2517. Epub 2009 Nov 20.
9
Should noninvasive ventilation be considered a high-risk procedure during an epidemic?在疫情期间，无创通气是否应被视为高风险操作？
CMAJ. 2009 Nov 10;181(10):663-4. doi: 10.1503/cmaj.081987. Epub 2009 Oct 13.
10
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.体外膜肺氧合治疗2009年甲型H1N1流感所致急性呼吸窘迫综合征
JAMA. 2009 Nov 4;302(17):1888-95. doi: 10.1001/jama.2009.1535. Epub 2009 Oct 12.
Zotero 插件